Omicron Linked to Increase in COVID-19 Cases, Lower Disease Severity

THURSDAY, Jan. 27, 2022 (HealthDay News) -- COVID-19 cases have increased with the emergence of the omicron variant, but disease severity seems not to have increased, according to research published in the Jan. 25 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
A. Danielle Iuliano, Ph.D., from the CDC COVID-19 Emergency Response Team, and colleagues examined data from three surveillance systems and a large health care database to understand the severity of disease and health care utilization associated with the emergence of the omicron variant in the United States. Multiple indicators were assessed across three high-COVID-19 transmission periods: Dec. 1, 2020, to Feb. 28, 2021 (winter 2020 to 2021); July 15 to Oct. 31, 2021 (delta predominance); and Dec. 19, 2021, to Jan. 15, 2022 (omicron predominance).
The researchers found that during the omicron period, the highest daily seven-day moving average to date of cases (798,976 daily cases during Jan. 9 to 15, 2022), emergency department visits (48,238), and admissions (21,586) were reported; compared with previous periods, the highest daily seven-day moving average of deaths was lower during omicron (1,854 deaths). A maximum of 20.6 percent of staffed inpatient beds were in use for COVID-19 patients during the omicron period, which was 3.4 and 7.2 percent higher than during the winter 2020 to 2021 and delta periods, respectively; intensive care unit (ICU) bed use did not increase to the same extent. Compared with the previous periods, during the omicron period, the mean length of stay and percentages admitted to ICU, who received invasive mechanical ventilation, and died in the hospital were lower.
"Although patients hospitalized during the omicron period have shorter stays and less frequent ICU admissions, the high volume of hospitalizations resulting from high transmission rates during a short period can strain local health care systems in the United States," the authors write.
One author disclosed financial ties to Becton, Dickinson and Company.
Related Posts
La COVID aumenta las probabilidades de diabetes en las personas sin vacunar
MIÉRCOLES, 15 de febrero de 2023 (HealthDay News) -- Una infección con la COVID...
Empresa retira el “Desafío de un solo chip” de estantes de las tiendas, después de que un adolescente fallece
VIERNES, 8 de septiembre de 2023 (Noticias HealthDay) -- El fabricante del...
Appeals Court Upholds Restrictions on Mifepristone
THURSDAY, Aug. 17, 2023 (HealthDay News) -- The abortion pill mifepristone...
Medicare Will Save U.S. Billions Negotiating Drug Prices
MONDAY, Jan. 30, 2023 (HealthDay News) -- The U.S. government could save...
